anubhai
Back OfficeNippon India Pharma Fund - Direct (IDCW)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund - Direct (IDCW) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 01-Jan-2013 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 8,569.15 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus | |
|---|---|---|
| Ratio | 100.00 | 0.00 |
| Record Date | 23-Feb-2024 | 0.00 |
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 1.41 | 3.37 | 7.56 | 5.40 | 13.30 | 25.29 | 22.53 | 18.97 |
| Category Avg | 1.79 | 4.64 | 8.11 | 4.42 | 15.33 | 25.41 | 22.26 | 17.75 |
| Category Best | 2.81 | 7.01 | 11.72 | 9.45 | 28.81 | 29.89 | 25.12 | 38.71 |
| Category Worst | 0.82 | 1.80 | 5.23 | -0.25 | 0.90 | 20.88 | 17.17 | -0.91 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 12.23 |
| Divi's Lab. | 8.50 |
| Lupin | 6.07 |
| Cipla | 5.62 |
| Apollo Hospitals | 5.48 |
| Dr Reddy's Labs | 5.18 |
| Medplus Health | 3.83 |
| Glaxosmi. Pharma | 3.63 |
| Narayana Hrudaya | 3.55 |
| Vijaya Diagnost. | 3.32 |
| Gland Pharma | 3.27 |
| Ajanta Pharma | 2.88 |
| Abbott India | 2.86 |
| Sai Life | 2.31 |
| Dr Lal Pathlabs | 2.31 |
| Zydus Lifesci. | 2.31 |
| Aurobindo Pharma | 2.25 |
| Pfizer | 2.11 |
| Mankind Pharma | 2.05 |
| Thyrocare Tech. | 2.04 |
| J B Chemicals & | 1.96 |
| Alkem Lab | 1.87 |
| Sanofi India | 1.71 |
| Biocon | 1.64 |
| Sanofi Consumer | 1.42 |
| Ipca Labs. | 1.27 |
| Suraksha Diagno. | 1.24 |
| Torrent Pharma. | 1.21 |
| Fortis Health. | 1.02 |
| Syngene Intl. | 0.95 |
| Emcure Pharma | 0.71 |
| Indoco Remedies | 0.68 |
| Astrazeneca Phar | 0.65 |
| Akums Drugs | 0.65 |
| Orchid Pharma | 0.41 |
| Concord Biotech | 0.24 |
| TREPS | 0.61 |
| Net CA & Others | -0.04 |
| C C I | 0.00 |
